Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.1K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.1K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

4.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.4K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.0K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.0K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

693
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
693
Frequency-dependent Selection01:21

Frequency-dependent Selection

24.1K
When the fitness of a trait is influenced by how common it is (i.e., its frequency) relative to different traits within a population, this is referred to as frequency-dependent selection. Frequency-dependent selection may occur between species or within a single species. This type of selection can either be positive—with more common phenotypes having higher fitness—or negative, with rarer phenotypes conferring increased fitness.
24.1K
Drug Dependence01:17

Drug Dependence

1.7K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of psychiatric emergency department visits within twelve months post-inpatient psychiatric discharge in Alberta, Canada.

PloS one·2026
Same author

Recalibrating the Quantitative Relationship Between Duration of Untreated Psychosis and Outcome for Health Service Models.

Early intervention in psychiatry·2026
Same author

Revisiting the earlier, pre-CHR-P prodrome of psychotic illness: a desideratum for advancing early intervention?

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same author

Gender differences in psychiatric diagnoses and patient-reported experiences with inpatient mental health care in Alberta.

Archives of psychiatric nursing·2026
Same author

Post-traumatic stress disorder in inpatient psychiatry staff: a narrative review.

Frontiers in psychiatry·2025
Same author

Posterior Sternoclavicular Joint Dislocation and Reconstruction.

Journal of orthopaedic trauma·2025

Related Experiment Video

Updated: Feb 5, 2026

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.7K

Hypogonadism in an opioid dependent man.

Nnamdi Nkire1, Michael Doran2, John J O'Connor2

  • 1Our Lady's Hospital Navan,Ireland.

Irish Journal of Psychological Medicine
|September 12, 2018
PubMed
Summary

Opioid use, including methadone maintenance therapy, can cause hypogonadism, leading to symptoms like gynecomastia and testicular atrophy. Testosterone replacement therapy can effectively manage these endocrine complications in opioid users.

More Related Videos

DNAzyme-dependent Analysis of rRNA 2’-O-Methylation
09:12

DNAzyme-dependent Analysis of rRNA 2’-O-Methylation

Published on: September 16, 2019

8.8K
State-Dependency Effects on TMS: A Look at Motive Phosphene Behavior
12:38

State-Dependency Effects on TMS: A Look at Motive Phosphene Behavior

Published on: December 28, 2010

11.0K

Related Experiment Videos

Last Updated: Feb 5, 2026

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.7K
DNAzyme-dependent Analysis of rRNA 2’-O-Methylation
09:12

DNAzyme-dependent Analysis of rRNA 2’-O-Methylation

Published on: September 16, 2019

8.8K
State-Dependency Effects on TMS: A Look at Motive Phosphene Behavior
12:38

State-Dependency Effects on TMS: A Look at Motive Phosphene Behavior

Published on: December 28, 2010

11.0K

Area of Science:

  • Endocrinology
  • Toxicology

Background:

  • Chronic opioid use, particularly methadone maintenance therapy, is prevalent.
  • Opioid-induced hypogonadism is an underrecognized endocrine complication.

Purpose of the Study:

  • To report a case of hypogonadism secondary to long-term methadone use.
  • To highlight the importance of recognizing and managing endocrine dysfunction in opioid users.

Main Methods:

  • Case report of a 45-year-old male on methadone maintenance therapy for 12 years.
  • Clinical assessment including history, physical examination, and laboratory investigations (sex hormone levels, liver function tests, thyroid function tests, MRI, viral screens).
  • Diagnosis of hypogonadism based on abnormal testosterone levels.

Main Results:

  • The patient presented with painful gynecomastia and testicular atrophy.
  • Abnormal sex hormone levels confirmed hypogonadism secondary to opioid use.
  • Parenteral testosterone replacement therapy provided therapeutic benefit.

Conclusions:

  • Opioid use is associated with significant endocrine complications, including hypogonadism.
  • Early detection and appropriate management, such as testosterone replacement, are crucial for patients using opioids.
  • Comprehensive sexual history and investigations are essential for identifying hormonal dysfunction.